Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents

被引：0
|
作者：
Marzo, M. [1 ]
Armuzzi, A. [1 ]
Felice, C. [1 ]
Forni, F. [1 ]
Papa, A. [1 ]
De Vitis, I [1 ]
Guidi, L. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Lab Med, Rome, Italy
来源：
INFLAMMATORY BOWEL DISEASES | 2009年 / 15卷 / 12期
关键词：
D O I：
10.1097/00054725-200912002-00118
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] FECAL CALPROTECTIN LEVELS AFTER INDUCTION WITH ANTI-TNF AGENTS IN INFLAMMATORY BOWEL DISEASE CORRELATES WITH THE CLINICAL RESPONSE
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Andrisani, G.
    Sparano, L.
    Vitale, G.
    Pugliese, D.
    Papa, A.
    De Vitis, I.
    Forni, F.
    Rapaccini, G.
    Guidi, L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 : S180 - S180
  • [2] Fecal Calprotectin Values in Inflammatory Bowel Disease Patients After Induction Course of Anti-TNF Agents: Correlation With the Clinical Response
    Guidi, Luisa
    Marzo, Manuela
    Felice, Carla
    Andrisani, Gianluca
    Sparano, Lucia
    Vitale, Giovanna
    Pugliese, Daniela
    Papa, Alfredo
    De Vitis, Italo
    Forni, Franca
    Rapaccini, Gian Ludovico
    Armuzzi, Alessandro
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S686 - S686
  • [3] PARADOXICAL INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH SPONDYLOARTHROPATHIES TREATED WITH ANTI-TNF AGENTS
    Ancuta, C.
    Pomirleanu, C.
    Paiu, R.
    Ancuta, E.
    Chirieac, R.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S66 - S66
  • [4] Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents
    Guerra, Ivan
    Gisbert, Javier P.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (01) : 41 - 48
  • [5] The efficiency of iron supplementation in inflammatory bowel disease patients treated with anti-TNF agents
    Kim, Su Young
    Kim, Yoon Jae
    Kim, Jung Ho
    Chung, Jun-Won
    Kwon, Kwang An
    Kim, Kyoung Oh
    Park, Dong Kyun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 473 - 473
  • [6] The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents
    Khan, Nabeel
    Trivedi, Chinmay
    Shah, Yash
    Patel, Dhruvan
    Lewis, James
    Yang, Yu-Xiao
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (06) : 1274 - 1279
  • [7] Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
    Robles, V.
    deGuise, C. Herrera
    Guirola, M. A.
    Borruel, N.
    Casellas, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S254 - S255
  • [8] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Campos, Sara T.
    Portela, Francisco A.
    Tome, Luis
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) : 645 - 650
  • [9] Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease
    Peng, Jiang Chen
    Shen, Jun
    Ran, Zhi Hua
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2014, 15 (11) : 585 - 590
  • [10] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Sara T. Campos
    Francisco A. Portela
    Luís Tomé
    [J]. International Journal of Colorectal Disease, 2017, 32 : 645 - 650
12345